Log in to search using one of your social media accounts:

 

3D-printed implants and scaffold technology – how bioengineering innovation could treat and prevent osteoarthritis
The need for new and effective ways to treat and preventosteoarthritis has never been more urgent. Demand for total joint replacements is rising every year, and expected to double by 2030, placing a huge strain on the NHS. Meanwhile, those living with the pain of early stage osteoarthritis or at risk of developing it due to injury face limited treatment options.That’s why Arthritis Research UK is investing in innovative research dedicated to developing medical technologies which could provide an answer. By 'medical technologies' we mean cutting-edge medical devices, orthotics, implants and imaging techniques, harness...
Source: Arthritis Research UK - November 23, 2017 Category: Rheumatology Source Type: news

FDA wants to improve access to generic abuse-deterrent opioids: here ’s how
The FDA commissioner, Dr. Scott Gottlieb, has made the opioid crisis a priority in his time at the agency. Yesterday, the regulatory body issued guidance to help promote the development of generic opioids designed to prevent abuse. To date, the FDA has approved 10 of these products, called abuse-deterrent opioids. But, as Gottlieb noted in a statement, uptake by physicians has been slow. Get the full story at our sister site, Drug Delivery Business News. The post FDA wants to improve access to generic abuse-deterrent opioids: here’s how appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 22, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Endo Pharmaceuticals Source Type: news

Opioid Use for Osteoarthritis Is Prevalent
A large percentage of patients with advanced knee, hip, or spine OA take opioids for their chronic pain. (Source: ConsultantLive)
Source: ConsultantLive - November 22, 2017 Category: Internal Medicine Authors: Gregory M. Weiss, M.D. Tags: Osteoarthritis Pain Pain Management Source Type: news

Using digital pills, researchers find patients consume fewer opioids than expected
Clinicians at Brigham and Women’s Hospital published a paper in the December issue of Anesthesia & Analgesia showing that digital pills successfully monitored patients taking opioids following an injury. To track the participants’ opioid use, researchers used etectRx‘s ID-Cap system, which includes a capsule embedded with an ingestible sensor. Get the full story at our sister site, Drug Delivery Business News. The post Using digital pills, researchers find patients consume fewer opioids than expected appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 21, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Hospital Care Pain Management Pharmaceuticals Research & Development Brigham & Women's Hospital etectrx Source Type: news

Opioid Use for Osteoarthritis Is Prevalent
A large percentage of patients with advanced knee, hip, or spine OA take opioids for their chronic pain. (Source: CancerNetwork)
Source: CancerNetwork - November 21, 2017 Category: Cancer & Oncology Authors: Gregory M. Weiss, M.D. Tags: Osteoarthritis Pain Pain Management Source Type: news

Integrative medicine approaches for pain treatment -- can they be an alternative to opioids?
(Wolters Kluwer Health) Can acupuncture and yoga help to fight the opioid epidemic? These and other integrative medicine approaches have shown at least preliminary evidence of effectiveness in pain management, according to an article in the December issue of Anesthesia& Analgesia -- a special thematic issue addressing the opioid crisis. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 21, 2017 Category: International Medicine & Public Health Source Type: news

NeuX, GoX Studio ink development deal for smart chronic pain stim
West Palm Beach, Fla.-based medtech firm NeuX Technologies said it inked a strategic alliance deal with GoX Studio looking to combine their technology platforms to improve treatments for chronic pain and musculoskeletal injuries. Through the deal, NeuX said it plans to combine its Interactive Neuromuscular Stimulation tech platform with GoX’s SmarWork platform to deliver improved diagnosing, treatment, measurement, monitoring and prevention for chronic pain and injuries, according to a press release. “Solutions for treating chronic pain and injuries often fail because they treat the symptoms. NeuX’s Inter...
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Pain Management goxstudio neuxtechnologies Source Type: news

After FDA nod, Flexion launches osteoarthritis injection
Flexion Therapeutics (NSDQ:FLXN) today launched its Zilretta therapy designed to help patients manage pain associated with osteoarthritis of the knee. The Burlington, Mass.-based company’s extended-release intra-articular injection combines a commonly administered, short-acting corticosteroid with a polylactic-co-glycolic acid matrix using Flexion’s microsphere technology. Get the full story at our sister site, Drug Delivery Business News. The post After FDA nod, Flexion launches osteoarthritis injection appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Orthopedics Pain Management Pharmaceuticals Wall Street Beat Flexion Therapeutics Source Type: news

Doctors are now prescribing non-medical pain management techniques for low back pain, such as yoga and meditation
(Natural News) People are less tolerant to pain nowadays, and it’s significantly reducing global productivity and adding more weight on opioid dependency. Lower back pain (LBP) is one of these intolerable pains that plague urban inhabitants. It is the leading cause of disability and is also the second most common reason for seeking medical attention.... (Source: NaturalNews.com)
Source: NaturalNews.com - November 18, 2017 Category: Consumer Health News Source Type: news

iVeena finishes pilot trial of sustained-release implant
iVeena Delivery Systems said earlier this month that it finished a pilot trial for its IVMED-10 bioerodible implant designed to treat pain and inflammation after cataract surgery. Placed during cataract surgery, the sustained-release implant delivers dexamethasone for two weeks from the lens capsule. Get the full story at our sister site, Drug Delivery Business News. The post iVeena finishes pilot trial of sustained-release implant appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Optical/Ophthalmic Pain Management Pharmaceuticals Surgical iveenadeliverysystems Source Type: news

Fibromyalgia Tied to Chronic Migraines
The frequency is significantly higher than in patients with chronic tension-type headaches and the symptoms are more severe. (Source: CancerNetwork)
Source: CancerNetwork - November 16, 2017 Category: Cancer & Oncology Authors: Gregory M. Weiss, M.D. Tags: Pain Pain Management Fibromyalgia Source Type: news

Fibromyalgia Tied to Chronic Migraines
The frequency is significantly higher than in patients with chronic tension-type headaches and the symptoms are more severe. (Source: ConsultantLive)
Source: ConsultantLive - November 16, 2017 Category: Internal Medicine Authors: Gregory M. Weiss, M.D. Tags: Pain Pain Management Fibromyalgia Source Type: news

New Pain Management Strategies Spelled Out
National initiatives are designed to provide education, advance research, solve the opioid crisis, and help patients. (Source: ConsultantLive)
Source: ConsultantLive - November 15, 2017 Category: Internal Medicine Authors: Mariah Zebrowski Leach, JD, MS Tags: Pain Pain Management Rheumatic Diseases Source Type: news

New Pain Management Strategies Spelled Out
National initiatives are designed to provide education, advance research, solve the opioid crisis, and help patients. (Source: CancerNetwork)
Source: CancerNetwork - November 15, 2017 Category: Cancer & Oncology Authors: Mariah Zebrowski Leach, JD, MS Tags: Pain Pain Management Rheumatic Diseases Source Type: news

Visiting the doctor for low back pain? Expect something different now...
(University of Sydney) If you visit your family doctor with low back pain (LBP), you may be surprised at the treatment options they suggest now. Recent changes to major international guidelines for the management of LBP mean that general practitioners (GP) are now unlikely to recommend pain medicines which were previously the go-to treatment. Instead of pain medicines, GPs might suggest non-medicinal approaches including yoga, mindfulness and various types of physiotherapy and psychological therapies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 15, 2017 Category: Biology Source Type: news

Scilex seeks EU nod for ZTlido lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that it filed a marketing authorization application seeking approval for its ZTlido lidocaine patch. The San Diego, Calif.-based company said it is pursuing a hybrid regulatory pathway with the Medicines and Healthcare Products Regulatory Agency in the U.K., which will serve as the lead review agency. The company also plans to file for review in other countries, including Germany, France, Spain, Italy and Ireland. Get the full story at our sister site, Drug Delivery Business News. The post Scilex seeks EU nod for ZTlido ...
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Scilex Pharmaceuticals Sorrento Therapeutics Source Type: news

Nurses' Knowledge and Attitudes About Pain Nurses' Knowledge and Attitudes About Pain
How might nurses'knowledge and attitudes regarding pain assessment and management impact patient satisfaction?Pain Management Nursing (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news

Watch the birdie! Pediatric hospitals find the distraction of VR helps with pain management
(Natural News) These days, virtual reality (VR) is often employed by people who want to enjoy an immersive gaming experience. However, according to a recent study, virtual reality can soon be used for pain management at pediatric hospitals. Aside from using technological advances to blur the lines between the game world and the real world,... (Source: NaturalNews.com)
Source: NaturalNews.com - November 12, 2017 Category: Consumer Health News Source Type: news

Shares in Titan Pharmaceuticals fall after Q3 miss
Shares in Titan Pharmaceuticals (NSDQ:TTNP) fell today after the company missed expectations on Wall Street with its third quarter results. The San Francisco, Calif.-based company posted a net loss of -$4.2 million on sales of $40,000 for the 3 months ended Sept. 30, for bottom-line loss of -60% on sales growth of 53.8% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Shares in Titan Pharmaceuticals fall after Q3 miss appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 9, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations MassDevice Earnings Roundup Pain Management Pharmaceuticals Wall Street Beat Titan Pharmaceuticals Source Type: news

Pain in Elite Athletes Pain in Elite Athletes
A better understanding of the neurophysiological, biomechanical and psychosocial influences on pain in athletes will help improve the management of pain associated with sport injuries.British Journal of Sports Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2017 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Medovex aims to help fight the opioid crisis with its DenerveX system
Late last month, the White House issued a statement declaring the opioid crisis a national health emergency. Many companies in the healthcare field are aware of this issue, but only a handful of pain-treating device makers are focused on fighting the crisis. Atlanta-based Medovex is aiming to be one of the few. Medovex produces the DenerveX system, a combined therapy device designed to treat patients with chronic lower back pain related to facet joint syndrome. It’s a system that prez & CEO Patrick Kullman is hopeful will both be successful and help stem the opioid crisis in the US. “We have made a cre...
Source: Mass Device - November 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Pain Management Spinal Medovex Source Type: news

Rivanna tackles epidural failure rates with its hand-held imaging device
When they were students in the biomedical engineering department at the University of Virginia, Will Mauldin and Kevin Owen found a problem that needed solving – anesthesiologists often fail to successfully place an epidural on their first try. It’s a problem that costs the medical system more than $1.5 billion each year, according to Rivanna Medical. “The failure rates are between 30 – 80% depending on the type of patient and the user’s skill. So, that sounded very high,” Mauldin told Drug Delivery Business News. “Meanwhile, ultrasound had basically taken over in the ane...
Source: Mass Device - November 7, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Hospital Care Imaging Pain Management Pharmaceuticals Spinal Rivanna Medical Source Type: news

The Benefits of Alternative Therapies
This article will take a look at two additional therapy practices that have been widely used by the U.S. and abroad. Specifically designed for trauma, Eye Movement Desensitization and Reprocessing (EMDR) works when a therapist leads a patient through a series of lateral eye movements while the patient focuses on traumatic memories. The goal is to reprocess these memories in an adaptive way — eliminating emotional distress and reducing physiological arousal.  Francine Shapiro, PhD, discovered the effects of EMDR by understanding “dual awareness”. When engaging in bilateral stimulation with memory, th...
Source: Psych Central - November 7, 2017 Category: Psychiatry Authors: Rebecca Lee Tags: Addictions Anxiety Cognitive-Behavioral Depression Eating Disorders Obsessive-Compulsive Disorder Psychology Psychotherapy PTSD Trauma Treatment Cbt Cognitive Behavioral Therapy EMDR Eye Movement Desensitization And Reprocessin Source Type: news

Medtronic & #039;s Tiny Pain Treatment Device Approved in Europe
Medtronic has seen its pain stimulation sales slip in recent quarters, but that could be about to change.  The company just received a CE mark for its Intellis platform for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in the management of certain types of chronic pain. This clearance to sell Intellis in Europe follows FDA approval of the Intellis SCS in September. The platform has a lot going for it, including its size. According to Medtronic, this is the world's smallest fully implantable SCS neurostimulator. The device is designed to simplify and improve the patient experience ...
Source: MDDI - November 7, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

Can virtual reality be used to manage pain at a pediatric hospital?
(Children's Hospital Los Angeles) In a study conducted to determine if virtual reality (VR) can be effectively used for pain management during medical procedures such as blood draw, findings showed that VR significantly reduced patients' and parents' perception of acute pain, anxiety and general distress during the procedure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2017 Category: International Medicine & Public Health Source Type: news

Medtronic wins CE Mark for Intellis SCS, PNS systems
Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union for its Intellis spinal cord stimulation and peripheral nerve stimulation systems designed to treat chronic pain. The Fridley, Minn.-based company touted the Intellis as the world’s smallest fully implantable SCS neurostim. The newly-cleared system includes improved battery performance and is managed through the use of a Samsung Galaxy Tab S2 tablet. “Medtronic’s goal is to simplify treatment and improve the patient experience with personalized therapy that provides long-term pain relief and helps restore function. The...
Source: Mass Device - November 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Neuromodulation/Neurostimulation Pain Management Regulatory/Compliance Medtronic Source Type: news

CAAT Refinement Symposium: November 30, Baltimore, MD
The Center for Alternatives to Animal Testing (CAAT) will present “Progress in Refinement: Enhancement of Scientific Integrity and Animal Well-Being” on November 30, 2017, at Johns Hopkins University in Baltimore, MD. This one-day symposium is for IACUC members and administrators, principal investigators, attending veterinarians, regulatory personnel and labor atory animal care staff. The program focuses on refinement and will include discussions on social housing, pain assessment and management, environmental enrichment, and other critical topics.  (Source: OLAW News)
Source: OLAW News - November 3, 2017 Category: Research Authors: hamptonl Source Type: news

7 medtech stories we missed this week: Nov. 3, 2017
[Image from unsplash.com]From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed to help doctors resect and remove intrauterine tissue easily in an office setting if used with the MyoSure hysteroscope. 2. IntraFuse wins FDA clearance for FlexThread fibula pin IntraFuse has received FDA 510(k) clearance for its FlexThread Fibula Pin System, ...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Endoscopic / Arthroscopic Oncology Orthopedics Pain Management Regulatory/Compliance Surgical Ultrasound Women's Health brhmedical CapsoVision Helomics Hologic Inc. IntraFuse MedTech Sensus Healthcare LLC Skyline Med Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight Funding available! The National Network of Libraries of Medicine, Middle Atlantic Region, is accepting applications for health information outreach, health literacy initiatives, emergency preparedness partnerships and health sciences library projects. Applications will be due by COB on December 1. See a recent blog post from Executive Director, Kate Flewelling for details, or review our funding opportunities and start your application today! Apply Today! Health science librarians are invited to participate in a rigorous onl...
Source: NN/LM Middle Atlantic Region Blog - November 3, 2017 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Advancing the Practice of Pain Management Under the HHS Opioid Strategy
Transforming how we treat pain and recalibrating the role opioid medications play in pain care are a critical part of reducing opioid harms. (Source: PHPartners.org)
Source: PHPartners.org - November 3, 2017 Category: International Medicine & Public Health Source Type: news

Retired professional footballers at higher risk of knee osteoarthritis
Retired professional footballers are far more prone to develop knee pain and osteoarthritis and face problems with their knees earlier in life than the average person, a study has revealed.The research was led by academics at The University of Nottingham and funded by Arthritis Research UK with collaborative support from FMARC (FIFA’s Medical and Research Centre), the Professional Footballers Association (PFA) and SPIRE Healthcare Group.The study reported that male ex-footballers were two to three times more likely to suffer from knee pain and knee osteoarthritis and require a total knee replacement, even after ...
Source: Arthritis Research UK - November 3, 2017 Category: Rheumatology Source Type: news

Advisory committee backs Indivior ’s once-monthly opioid use disorder treatment
The post Advisory committee backs Indivior’s once-monthly opioid use disorder treatment appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 1, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat indivior Source Type: news

PAINWeekEnd Seattle Presents CE/CME Pain Management for Frontline...
A full day of pain management education on November 18; mingle with faculty and attendees, learn and earn up to 6.0 AMA PRA Category 1 credits for $129(PRWeb October 30, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14833916.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 30, 2017 Category: Pharmaceuticals Source Type: news

Why Don't Fibromyalgia Patients Stay on Their Meds?
(MedPage Today) -- Jack Cush, MD, reports widespread problem with drug compliance (Source: MedPage Today Pain Management)
Source: MedPage Today Pain Management - October 29, 2017 Category: Anesthesiology Source Type: news

Literature Review Shows Options for Neuropathy in Long-Term Care
The literature has imperfect but important messages for long-term care regarding neuropathic pain management: the long-term care population “can still benefit from careful opioid prescribing,” that nonpharmacologic therapies have a role, and that among the non-opioid pharmacologic options “gabapentin, pregabalin, venlafaxine, and duloxetine have the best evidence for benefit.” (Source: Caring for the Ages)
Source: Caring for the Ages - October 28, 2017 Category: Health Management Authors: Christine Kilgore Source Type: news

Lifestyle strategies for pain management
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - October 28, 2017 Category: Consumer Health News Source Type: news

Guidelines on Bone-modifying Agents in Metastatic Breast Cancer Updated Guidelines on Bone-modifying Agents in Metastatic Breast Cancer Updated
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) have updated their joint recommendations on bone-modifying agents (BMAs) for women with metastatic breast cancer, with an emphasis on dosing intervals and management of bone pain.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 27, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Dental Pharmacology Expert Tom Viola, RPh, CCP Launches New Informational Website
“Pharmacology Declassified” Web Site Specifically-Designed to Simplify the Increasingly Complex Pharmacology Landscape for The Entire Dental TeamColumbus, NJ – October 24, 2017 –Tom Viola, RPh, CCP, a world-renowned authority on dental pharmacology, recently launched a new web site (www.TomViola.com) to support and expand hispopular “Pharmacology Declassified”educational platform.According to Viola, “Dental professionals are tasked with the safe and effective management of medically-complex patients – especially with the aging of baby boomers and as we evolve into an oral-sys...
Source: Dental Technology Blog - October 27, 2017 Category: Dentistry Source Type: news

AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
FDA grants priority review to medicines it determines have potential to provide significant improvements in the safety and effectiveness of the treatment of a serious disease Priority designation shortens the review period from the standard 10 months to... Biopharmaceuticals AbbVie, Neurocrine Biosciences, elagolix, endometriosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 27, 2017 Category: Pharmaceuticals Source Type: news

AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
NORTH CHICAGO, Ill., Oct. 27, 2017 /PRNewswire/ -- AbbVie (NYSE:ABBV), a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 27, 2017 Category: Drugs & Pharmacology Source Type: news

Myoscience launches Iovera TKA pain management, opioid reduction trial
Myoscience said today it launched a clinical trial aiming to investigate its Iovera pain management system in treating post-surgical knee patients, with the 1st patient enrolled at Memphis, Tenn.’s Campbell Clinic. The Fremont, Calif.-based company’s Iovera technology is a non-opioid and non-systemic treatment designed to block pain signals from the peripheral nerves. Myoscience said the Iovera treatment uses the body’s natural response to cold to treat peripheral nerves, causing a sensory nerve to stop sending pain signals after receiving targeted cold therapy that is part of the treatment. The effect is...
Source: Mass Device - October 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Orthopedics Pain Management Myoscience Source Type: news

Pain Experts Push for Coverage of Alternative Therapies Pain Experts Push for Coverage of Alternative Therapies
Clinicians, health insurers, and other stakeholders are meeting to discuss the possibility of extending health coverage to include complementary and alternative therapies for pain management.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Medical Food May Help Control Inflammatory Pain Medical Food May Help Control Inflammatory Pain
When used as part of the clinical management of chronic inflammatory pain, a medical food appears to reduce pain without the need to increase opioid dosing.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Stem the Tide: Addressing the Opioid Epidemic
American Hospital Association. 10/2017 This 27-page toolkit provides resources about the opioid epidemic for hospitals and health systems to share with clinicians and patients, and to use to enhance partnerships within their communities. The information is categorized into eight topic areas: Clinician education on prescribing practices; Nonopioid pain management; Addressing stigma; Treatment options for opioid use disorders; Patient, family, and caregiver education; Transitions of care; Safeguarding against diversion; and Collaborating with communities. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - October 24, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Academy of Integrative Pain Management (AIPM) 28th Annual Meeting Academy of Integrative Pain Management (AIPM) 28th Annual Meeting
Read clinically focused news coverage of key developments from AIPM 2017Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2017 Category: Consumer Health News Tags: Conference Coverage Source Type: news

Hip and knee replacement patients using fewer opioids to manage pain after surgery
(American Society of Anesthesiologists) Opioid use in patients recovering from hip and knee replacement decreased by one-third between 2006 and 2014, reflecting success in efforts to promote a multimodal approach to pain management (using a variety of methods to manage pain) rather than using opioids alone, reveals new research being presented at the ANESTHESIOLOGY ® 2017 annual meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 21, 2017 Category: International Medicine & Public Health Source Type: news

Opioid Blocker as Good as Suboxone in First Head-to-Head Trial (CME/CE)
(MedPage Today) -- Monthly naltrexone (Vivitrol) non-inferior to buprenorphine/naloxone (Source: MedPage Today Pain Management)
Source: MedPage Today Pain Management - October 20, 2017 Category: Anesthesiology Source Type: news

Roundup: FDA digital health clearances and news in Q3 2017
Led by a new commissioner in Dr. Scott Gottlieb, the FDA had a busy few months with a handful of digital and mobile technologies getting cleared in the third quarter of 2017. Consumer-focused diabetes and pain management offerings were prominent, but but by and large the clearances hit a multitude of clinical concerns and, of note, even included the first software-only digital therapeutic. (Source: mobihealthnews)
Source: mobihealthnews - October 20, 2017 Category: Information Technology Source Type: news

Opioid Not Best Migraine Choice (CME/CE)
(MedPage Today) -- Drug combo provided faster, sustained pain relief in more patients (Source: MedPage Today Pain Management)
Source: MedPage Today Pain Management - October 19, 2017 Category: Anesthesiology Source Type: news

Anika ’ s Monovisc therapy gets green light in Australia
Anika Therapeutics (NSDQ:ANIK) said yesterday that regulatory authorities in Australia approved the company’s single injection viscosupplement, Monovisc, for the treatment of pain associated with osteoarthritis of the synovial joints. This latest regulatory win means that Monovisc is commercially available in more than twenty countries, including the U.S. and Canada. The Bedford, Mass.-based company said it plans to move into additional international markets next year with its therapy for hip and knee pain. Get the full story at our sister site, Drug Delivery Business News. The post Anika’s Monovisc therap...
Source: Mass Device - October 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Orthopedics Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Anika Therapeutics Inc. Source Type: news